Over the past six months, I dedicated significant effort to cancer research using Grok, focusing on microfluidic biochips, single-cell separation, and CTC detection technologies. While Grok proved to be a capable and insightful AI assistant, the inherent complexity of oncology—spanning molecular pathways, heterogeneous data, and multi-omics integration—often demanded extensive manual refinement, repeated iterations, and additional validation steps. However, after integrating Claude AI with coding capabilities, I discovered a far more efficient platform. This combination has dramatically streamlined literature synthesis, data analysis, workflow automation, and hypothesis generation. As a result, I can now complete future research projects in half the time or even less effort compared to using Grok alone, accelerating progress in precision oncology and enabling faster translation of complex findings into practical applications. You can click the link of my cancer research detail as follow: https://www.linkedin.com/pulse/unveiling-comprehensive-cancer-insights-solo-journey-data-danny-chan-coosc/